Marketing-authorisation holder · United States
Sucampo Pharma LLC
2 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
2 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| AMITIZA24mcg | 8mcg · Capsule | Lubiprostone | United States | Marketed | 2006 |
| RESCULA0.15% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Solution/drops | Unoprostone | United States | Not marketed | 2000 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 2 | 2 | 0 | CompaniesAll medicines |
Top substances
The active substances in most of its medicines.